DLH HOLDINGS CORP (DLHC) Stock Fundamental Analysis
USA - NASDAQ:DLHC - US23335Q1004 - Common Stock
5.5 USD
0 (0%)
Overall DLHC gets a fundamental rating of 3 out of 10. We evaluated DLHC against 82 industry peers in the Professional Services industry. While DLHC is still in line with the averages on profitability rating, there are concerns on its financial health. DLHC has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year DLHC was profitable.
In the past year DLHC had a positive cash flow from operations.
In the past 5 years DLHC has always been profitable.
In the past 5 years DLHC always reported a positive cash flow from operatings.
1.2 Ratios
DLHC has a Return On Assets (1.53%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 4.03%, DLHC is in line with its industry, outperforming 45.12% of the companies in the same industry.
With a Return On Invested Capital value of 6.51%, DLHC perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DLHC is in line with the industry average of 13.40%.
The last Return On Invested Capital (6.51%) for DLHC is well below the 3 year average (11.89%), which needs to be investigated, but indicates that DLHC had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| ROIC | 6.51% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
1.3 Margins
DLHC has a Profit Margin (1.27%) which is in line with its industry peers.
DLHC's Profit Margin has declined in the last couple of years.
DLHC's Operating Margin of 5.81% is in line compared to the rest of the industry. DLHC outperforms 52.44% of its industry peers.
In the last couple of years the Operating Margin of DLHC has declined.
DLHC has a Gross Margin of 19.88%. This is in the lower half of the industry: DLHC underperforms 76.83% of its industry peers.
DLHC's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.81% | ||
| PM (TTM) | 1.27% | ||
| GM | 19.88% |
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DLHC is still creating some value.
Compared to 1 year ago, DLHC has more shares outstanding
The number of shares outstanding for DLHC has been increased compared to 5 years ago.
DLHC has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.76, we must say that DLHC is in the distress zone and has some risk of bankruptcy.
DLHC has a worse Altman-Z score (1.76) than 69.51% of its industry peers.
The Debt to FCF ratio of DLHC is 5.74, which is a neutral value as it means it would take DLHC, 5.74 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DLHC (5.74) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.09 is on the high side and indicates that DLHC has dependencies on debt financing.
DLHC has a worse Debt to Equity ratio (1.09) than 71.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.09 | ||
| Debt/FCF | 5.74 | ||
| Altman-Z | 1.76 |
ROIC/WACC0.68
WACC9.57%
2.3 Liquidity
DLHC has a Current Ratio of 1.08. This is a normal value and indicates that DLHC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DLHC (1.08) is worse than 70.73% of its industry peers.
DLHC has a Quick Ratio of 1.08. This is a normal value and indicates that DLHC is financially healthy and should not expect problems in meeting its short term obligations.
DLHC has a Quick ratio of 1.08. This is in the lower half of the industry: DLHC underperforms 70.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for DLHC have decreased strongly by -37.25% in the last year.
Measured over the past 5 years, DLHC shows a small growth in Earnings Per Share. The EPS has been growing by 1.22% on average per year.
The Revenue for DLHC has decreased by -10.30% in the past year. This is quite bad
Measured over the past years, DLHC shows a quite strong growth in Revenue. The Revenue has been growing by 19.81% on average per year.
EPS 1Y (TTM)-37.25%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.3%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-17.23%
3.2 Future
Based on estimates for the next years, DLHC will show a very negative growth in Earnings Per Share. The EPS will decrease by -59.37% on average per year.
Based on estimates for the next years, DLHC will show a very negative growth in Revenue. The Revenue will decrease by -21.79% on average per year.
EPS Next Y-66%
EPS Next 2Y-59.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.41%
Revenue Next 2Y-21.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.19, which indicates a rather expensive current valuation of DLHC.
DLHC's Price/Earnings ratio is a bit cheaper when compared to the industry. DLHC is cheaper than 65.85% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.40, DLHC is valued a bit cheaper.
DLHC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.19 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DLHC is valued cheaper than 95.12% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DLHC is valued cheaper than 98.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.28 | ||
| EV/EBITDA | 5.75 |
4.3 Compensation for Growth
A cheap valuation may be justified as DLHC's earnings are expected to decrease with -59.37% in the coming years.
PEG (NY)N/A
PEG (5Y)14.09
EPS Next 2Y-59.37%
EPS Next 3YN/A
5. Dividend
5.1 Amount
DLHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:DLHC (10/17/2025, 8:06:54 PM)
5.5
0 (0%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners67.83%
Inst Owner Change0%
Ins Owners13.55%
Ins Owner Change1.32%
Market Cap79.14M
Analysts82.86
Price Target10.2 (85.45%)
Short Float %0.79%
Short Ratio3.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.96%
Min EPS beat(2)-15.97%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)9.18%
Min EPS beat(4)-15.97%
Max EPS beat(4)42.6%
EPS beat(8)4
Avg EPS beat(8)3.31%
EPS beat(12)6
Avg EPS beat(12)0.33%
EPS beat(16)8
Avg EPS beat(16)2.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.19%
Min Revenue beat(2)-2.82%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-4.76%
Min Revenue beat(4)-8.25%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-3.95%
Revenue beat(12)1
Avg Revenue beat(12)-4.15%
Revenue beat(16)3
Avg Revenue beat(16)-2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.19 | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | 3.28 | ||
| P/OCF | 3.23 | ||
| P/B | 0.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.75 |
EPS(TTM)0.32
EY5.82%
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)1.68
FCFY30.47%
OCF(TTM)1.71
OCFY31%
SpS25
BVpS7.9
TBVpS-8.37
PEG (NY)N/A
PEG (5Y)14.09
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.53% | ||
| ROE | 4.03% | ||
| ROCE | 8.24% | ||
| ROIC | 6.51% | ||
| ROICexc | 6.51% | ||
| ROICexgc | 86.01% | ||
| OM | 5.81% | ||
| PM (TTM) | 1.27% | ||
| GM | 19.88% | ||
| FCFM | 6.7% |
ROA(3y)5.52%
ROA(5y)5.11%
ROE(3y)11.15%
ROE(5y)12.44%
ROIC(3y)11.89%
ROIC(5y)11.02%
ROICexc(3y)11.91%
ROICexc(5y)11.55%
ROICexgc(3y)142.07%
ROICexgc(5y)N/A
ROCE(3y)15.05%
ROCE(5y)13.95%
ROICexcg growth 3YN/A
ROICexcg growth 5Y-9.4%
ROICexc growth 3Y-17.74%
ROICexc growth 5Y-3.87%
OM growth 3Y-5.45%
OM growth 5Y-2.42%
PM growth 3Y-23.19%
PM growth 5Y-10.78%
GM growth 3Y-1.6%
GM growth 5Y-2.24%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.09 | ||
| Debt/FCF | 5.74 | ||
| Debt/EBITDA | 3.29 | ||
| Cap/Depr | 2.51% | ||
| Cap/Sales | 0.12% | ||
| Interest Coverage | 1.45 | ||
| Cash Conversion | 64.97% | ||
| Profit Quality | 526.26% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 1.76 |
F-Score7
WACC9.57%
ROIC/WACC0.68
Cap/Depr(3y)6.77%
Cap/Depr(5y)4.74%
Cap/Sales(3y)0.2%
Cap/Sales(5y)0.14%
Profit Quality(3y)813.86%
Profit Quality(5y)632.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-37.25%
EPS 3Y-11.67%
EPS 5Y1.22%
EPS Q2Q%-75%
EPS Next Y-66%
EPS Next 2Y-59.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-10.3%
Revenue growth 3Y17.18%
Revenue growth 5Y19.81%
Sales Q2Q%-17.23%
Revenue Next Year-13.41%
Revenue Next 2Y-21.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.78%
EBIT growth 3Y10.79%
EBIT growth 5Y16.91%
EBIT Next Year43.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.84%
FCF growth 3Y-16.5%
FCF growth 5Y8.52%
OCF growth 1Y16.84%
OCF growth 3Y-15.69%
OCF growth 5Y8.69%